Metformin yana ƙara ƙarancin sinadarin B12, wanda kwakwalwa ke buƙata. Sai dai wani sabon bincike kan manya 587 da ke da ciwon sukari nau’in 2 ya nuna cewa masu shan metformin sun samu maki mafi girma a gwajin tunani, kusan 3.5–3.75 fiye da wadanda ba su amfani da shi. Matakan B12 da MMA ba su iya bayyana wannan bambanci ba, kuma kusan kashi 95 % na alaƙar ta kasance kai tsaye. Amfanin ya fi bayyana a tsakanin masu shekaru 60‑69 da waɗanda suka fara da ƙananan maki. Duk da haka, binciken na tsinkaye ne kawai, ba zai iya tabbatar da kariyar kwakwalwa daga metformin ba.
This page is available in